(Natural News) It would be naive to think that the FDA endeavors to protect the public’s health as its primary focus. Indeed, that would be a conflict of interest, as it serves its master, the pharmaceutical industry. Has the Food and Drug Administration engineered a shortage of intravenous vitamin C as part of an overall attack on natural and non-toxic approaches to healing that compete with prescription drugs? An analysis by Natural Blaze would suggest that the answer is yes.
Natural Blaze claims that a critical shortage of IV bags in general followed an FDA ban on the mass production of intravenous vitamin C. The FDA limited the availability of IV-C and the pharmaceutical industry halted production of injectable vitamins and minerals, after a 60 minute story about the miraculous recovery of a swine flu patient on life support. Because of the shortage of IV-C, doctors called upon compounding pharmacies to produce it. But the FDA began to limit compounding pharmacies after injectable steroids produced by the New England Compounding Center were contaminated with a fungus that caused a deadly outbreak of meningitis. Here is an example of an entire industry being punished for the dubious practices of one compounding pharmacy.
Try and follow this convoluted story: Doctors began to source NECC for its more expensive product because cheaper generic versions were in short supply. But it was the FDA’s increased inspection of drug factories that disrupted the supply chain in the first place. So the meningitis deaths were in part caused by the onerous actions of the FDA.
Natural Blaze reports, “… without anyone noticing, and by many indirect means of banning production of the bags or shutting down those doing the production of the bags and the injectable vitamins and minerals, access to IV solutions for innumerable treatments for diseases, have gone into critical shortage.”…